Muscarinic receptor subtypes in airways

https://doi.org/10.1016/0024-3205(93)90310-YGet rights and content

Abstract

Muscarinic receptor subtypes in the airways appear to subserve different physiological functions. M1-receptors facilitate neurotransmission through parasympathetic ganglia and enhance cholinergic reflexes, but are also localized to alveolar walls. M2-receptors act as autoreceptors on post-ganglionic cholinergic nerves and inhibit acetylcholine release. There is some evidence that they may be defective in asthma (as a consequence of airway inflammation?) and this may enhance cholinergic reflexes and account for β-blocker-induced asthma. M2-receptors in airway smooth muscle may also counteract the bronchodilator action of β-agonist. M3-receptors mediate contractile responses in airway smooth muscle via phosphoinositide hydrolysis, and are the predominant receptors on submucosal glands and airway vascular endothelium. M4- and M5-receptors have not been identified in human airways, but in rabbit lung M4-receptors are expressed on alveolar walls and smooth muscle. Anticholinergic drugs which selectively block M3 and M1-receptors may have an advantage over currently used non-selective antagonists in the treatment of airway obstruction.

References (48)

  • P.J. Barnes et al.

    Eur. J. Pharmacol.

    (1982)
  • N.J. Gross et al.

    Chest

    (1989)
  • J.C.W. Mak et al.

    Eur. J. Pharmacol.

    (1989)
  • J.W. Bloom et al.

    Eur J Pharmacol

    (1987)
  • J.H. Ashe et al.

    Neuropharmacology

    (1984)
  • A.F. Roffel et al.

    Eur. J. Pharmacol.

    (1988)
  • A.F. Roffel et al.

    Pulm. Pharmacol.

    (1990)
  • E.R. Chilvers et al.

    Eur. J. Pharmacol.

    (1989)
  • D.G. McCormack et al.

    Eur. J. Pharmacol.

    (1988)
  • P.J. Barnes

    Am. Rev. Respir. Dis.

    (1986)
  • K. Tokuyama et al.

    Am J Physiol

    (1990)
  • J.C.W. Mak et al.

    Am. Rev. Respir. Dis.

    (1990)
  • C.J. van Koppen et al.

    Neursci Lett

    (1989)
  • P.J. Barnes

    J. Appl. Physiol.

    (1990)
  • P.A. Minette et al.

    Am Rev Respir Dis

    (1990)
  • J. Maclagan et al.

    Trends Pharmacol. Sci.

    (1989)
  • J.C.W. Mak et al.

    Am J Resp Cell Mol Biol

    (1992)
  • J.W. Bloom et al.

    J. Pharmacol. Exp. Ther.

    (1987)
  • T.B. Casale et al.

    J. Appl. Physiol.

    (1988)
  • P.J. Barnes

    Physiol Rev

    (1992)
  • J.-W.J. Lammers et al.

    Am. Rev. Respir. Dis.

    (1989)
  • K. Sertl et al.

    Int J Clin Pharmacol Ther Toxicol

    (1986)
  • M. Cazzola et al.

    Int J Clin Pharmacol Ther Toxicol

    (1987)
  • D. Ukena et al.

    Eur Resp J

    (1992)
  • Cited by (224)

    • Neuroscience and treatment of asthma, new therapeutic strategies and future aspects

      2022, Life Sciences
      Citation Excerpt :

      They are also present in airway smooth muscle and counteract the bronchodilator action of β-agonists. Contractile responses in airway smooth muscles are mediated through M3 receptors, a subtype of muscarinic receptors that are also present on the submucosal gland and epithelial cells in the human airway [69]. Muscarinic receptors are the therapeutic target for many lung diseases such as asthma and COPD [70].

    • Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD

      2018, Pulmonary Pharmacology and Therapeutics
      Citation Excerpt :

      Long-acting muscarinic antagonists (LAMA) in combination with long-acting beta2-agonists are increasingly being used to treat chronic obstructive pulmonary disease (COPD) due to greater improvement in lung function and symptom scores [1–5]. Both classes of bronchodilators relax airway smooth muscle and thereby reduce respiratory muscle activity and dynamic hyperinflation and improve ventilatory mechanics [6–8]. In patients with COPD, the use of LAMA, as compared to placebo, reduced lung hyperinflation and inspiratory capacity at rest and during exercise contributing to improvement in exertional dyspnea and increased exercise endurance [8].

    • Genetics in Asthma and COPD

      2015, Murray and Nadel's Textbook of Respiratory Medicine: Volume 1,2, Sixth Edition
    • Development of the Innervation of the Lower Airways: Structure and Function. Structure and Function.

      2014, The Lung: Development, Aging and the Environment: Second Edition
    View all citing articles on Scopus
    View full text